Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyrrolidine | HCID 31268 | — |
| Reactant | HCID 86749448 | HCID 86749448 | — |
| Product | HCID 86749447 | HCID 86749447 | — |
Reaction Steps
After adding 2.00 g (3.81 mmoles) of 1- (3α,16α)-eburnamenine-14-carbonyl!-4-(2,4-dichloro-6-pyrimidinyl)piperazine in small portions to 20 ml of pyrrolidine at a temperature below 10° C., the reaction mixture is stirred at room temperature for 1 hour, then evaporated. After distributing the evaporation residue between 40 ml of chloroform and 10 ml of 1% sodium hydroxide solution the organic phase is separated, dried and evaporated. The evaporation residue is subjected to chromatography on a silica gel column. By using a 99:1 mixture of chloroform and methanol the less polar 1- (3α,16α)-eburnamenine-14-carbonyl!-4-(4-chloro-2-pyrrolidino-6-pyrimidinyl)piperazine is first eluted from the column, which is recrystallized from a mixture of ether and hexane to give a yield of 2.01 g (88.2%), m.p.: 210°-220° C. By further elution the more polar 1- (3α,16α)-eburnamenine-14-carbonyl!-4-(2-chloro-4-pyrrolidino-6-pyrimidinyl)piperazine is obtained which is similarly recrystallized from a mixture of ether and hexane to give a yield of 0.13 g (5.7%), m.p.: 169°-200° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05510345 |
|---|
| Source dataset | uspto-grants-1996_04 |
|---|
| ORD ID | ord-3a6296eadc2249acbd9ae45910d8471f |
|---|
| Source note | uspto-grants-1996_04 |
|---|